2m 2m 2m 2m 2m 2m 2m
PYXIS ONCOLOGY (PYXS)
NASDAQ
$2.19+$0.09 (+4.24%)
Price as of Jun 23, 2026 7:07 PM EDT- $134.9MMarket Cap
- 64.06%1-Year Change
- BiotechnologyIndustry
PYXIS ONCOLOGY (PYXS)
$2.19+$0.09 (+4.24%)
PYXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.10 | ||
Change | -$0.03 (-1.41%) | ||
Open | $2.08 | ||
High | $2.26 | ||
Low | $2.07 | ||
Previous Close | $2.13 | ||
Volume | 408,027 | ||
30-Day Average Volume | 483,732 | ||
1-Week Change | 20.00% | ||
1-Month Change | 7.14% | ||
1-Year Change | 64.06% | ||
3-Year Change | -21.05% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 63.4M | ||
Total Assets | $64.3M | ||
Market Cap | $134.9M | ||
Enterprise Value | $129.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$23.3M | ||
Free Cash Flow | -$26.0M | ||
EBIT | -$23.3M | ||
EBITDA | -$22.8M | ||
Net Working Capital | $29.0M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue